All Stories

  1. Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients

    Article • Clinical Journal of the American Society of Nephrology, April 2020, American Society of Nephrology

    David Goldfarb

  2. Water to prevent kidney stones: tap vs bottled; soft vs hard - does it matter?

    Article • BJU International, August 2019, Wiley

    David Goldfarb

  3. The use of antibiotics and risk of kidney stones

    Article • Current Opinion in Nephrology & Hypertension, July 2019, Wolters Kluwer Health

    David Goldfarb

  4. Recurrent Calcium Kidney Stones

    Article • Clinical Journal of the American Society of Nephrology, June 2019, American Society of Nephrology

    David Goldfarb

  5. Effect of thiazolidinedione therapy on the risk of uric acid stones

    Article • Kidney International, May 2019, Elsevier

    David Goldfarb

  6. Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria

    Article • Urolithiasis, April 2019, Springer Science + Business Media

    David Goldfarb

  7. A Twin Study of Genetic Influences on Nephrolithiasis in Women and Men

    Article • Kidney International Reports, April 2019, Elsevier

    David Goldfarb

  8. Sex differences in the temperature dependence of kidney stone presentations: a population-based aggregated case-crossover study

    Article • Urolithiasis, March 2019, Springer Science + Business Media

    David Goldfarb

  9. Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts

    Article • Pediatric Nephrology, March 2019, Springer Science + Business Media

    David Goldfarb

  10. Editorial

    Article • Current Opinion in Nephrology & Hypertension, March 2019, Wolters Kluwer Health

    David Goldfarb

  11. Differences in national and international guidelines regarding use of kidney stone formers as living kidney donors

    Article • Current Opinion in Nephrology & Hypertension, March 2019, Wolters Kluwer Health

    David Goldfarb

  12. Blood volume analysis as a guide for dry weight determination in chronic hemodialysis patients: a crossover study

    Article • BMC Nephrology, February 2019, Springer Science + Business Media

    David Goldfarb

  13. Access to Care for VA Dialysis Patients During Superstorm Sandy

    Article • Journal of Primary Care & Community Health, January 2019, SAGE Publications

    David Goldfarb

  14. Urine proteomic profiling in patients with nephrolithiasis and cystinuria

    Article • International Urology and Nephrology, December 2018, Springer Science + Business Media

    David Goldfarb

  15. Cystinuria: genetic aspects, mouse models, and a new approach to therapy

    Article • Urolithiasis, December 2018, Springer Science + Business Media

    David Goldfarb

  16. Empiric therapy for kidney stones

    Article • Urolithiasis, November 2018, Springer Science + Business Media

    David Goldfarb

  17. Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout

    Article • Rheumatology, August 2018, Oxford University Press (OUP)

    David Goldfarb

  18. Managing protein-energy wasting in hemodialysis patients: A comparison of animal- and plant-based protein foods

    Article • Seminars in Dialysis, July 2018, Wiley

    David Goldfarb

  19. Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia

    Article • AJP Renal Physiology, June 2018, American Physiological Society

    David Goldfarb

  20. Assessment and misassessment of potassium, phosphorus, and protein in the hemodialysis diet

    Article • Seminars in Dialysis, May 2018, Wiley

    David Goldfarb

  21. Oral Antibiotic Exposure and Kidney Stone Disease

    Article • Journal of the American Society of Nephrology, May 2018, American Society of Nephrology

    Gregory Tasian, David Goldfarb

  22. Assessment of the combination of temperature and relative humidity on kidney stone presentations

    Article • Environmental Research, April 2018, Elsevier

    David Goldfarb

  23. Personalized Intervention in Monogenic Stone Formers

    Article • The Journal of Urology, March 2018, Wolters Kluwer Health

    David Goldfarb

  24. Chronic pain in medullary sponge kidney: a rare and never described clinical presentation

    Article • Journal of Nephrology, February 2018, Springer Science + Business Media

    David Goldfarb

  25. Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial

    Article • European Journal of Internal Medicine, February 2018, Elsevier

    David Goldfarb

  26. Falsely elevated salicylate concentration in a patient with hypertriglyceridemia

    Article • Toxicology Communications, January 2018, Taylor & Francis

    David Goldfarb

  27. The Healthy Hearts and Kidneys (HHK) study: Design of a 2 × 2 RCT of technology-supported self-monitoring and social cognitive theory-based counseling to engage overweight people with diabetes and chronic kidney disease in multiple lifestyle changes

    Article • Contemporary Clinical Trials, January 2018, Elsevier

    David Goldfarb

  28. Diet Quality Assessed via the Healthy Eating Index – 2010 among Overweight/Obese Individuals with Type 2 Diabetes and Concurrent Chronic Kidney Disease

    Article • Journal of the Academy of Nutrition and Dietetics, September 2017, Elsevier

    David Goldfarb

  29. Commentary about the diagnosis of incomplete distal RTA

    Article • Clinical Journal of the American Society of Nephrology, August 2017, American Society of Nephrology

    David Goldfarb

  30. Opioid Overuse or NSAID Underuse? A Response to the Pain Guide

    Article • American Journal of Kidney Diseases, June 2017, Elsevier

    David Goldfarb

  31. THU0455 Renal safety of lesinurad: a pooled analysis of phase iii and extension studies

    Article • June 2017, BMJ

    David Goldfarb

  32. Phosphate Additive Avoidance in Chronic Kidney Disease

    Article • Diabetes Spectrum, May 2017, American Diabetes Association

    David Goldfarb

  33. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease

    Article • Seminars in Dialysis, April 2017, Wiley

    Professor Kamyar Kalantar-Zadeh, Dr Tushar Vachharajani , Dr. Yoshitsugu Obi, David Goldfarb

  34. The Role of the 24-Hour Urine Collection in the Prevention of Kidney Stone Recurrence

    Article • The Journal of Urology, April 2017, Wolters Kluwer Health

    David Goldfarb

  35. Does Vitamin D Supplementation Cause Kidney Stones?

    Article • The Journal of Urology, February 2017, Wolters Kluwer Health

    David Goldfarb

  36. The role of the microbiome in kidney stone formation

    Article • International Journal of Surgery, December 2016, Elsevier

    David Goldfarb

  37. Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?

    Article • Journal of Renal Nutrition, September 2016, Elsevier

    David Goldfarb

  38. l-Cystine Diamides asl-Cystine Crystallization Inhibitors for Cystinuria

    Article • Journal of Medicinal Chemistry, July 2016, American Chemical Society (ACS)

    David Goldfarb

  39. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement

    Article • Journal of Nephrology, July 2016, Springer Science + Business Media

    Sandro Mazzaferro, Prof Giuseppe Vezzoli, David Goldfarb, Dr Ziya Kirkali

  40. A RANKL Wrinkle: Denosumab-Induced Hypocalcemia

    Article • Journal of Medical Toxicology, March 2016, Springer Science + Business Media

    David Goldfarb

  41. Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health

    Article • Clinical Journal of the American Society of Nephrology, March 2016, American Society of Nephrology

    Dr Ziya Kirkali, David Goldfarb

  42. The Presence of Oxalobacter formigenes in the Microbiome of Healthy Young Adults

    Article • The Journal of Urology, February 2016, Wolters Kluwer Health

    David Goldfarb

  43. Hypothesis: Urbanization and exposure to urban heat islands contribute to increasing prevalence of kidney stones

    Article • Medical Hypotheses, December 2015, Elsevier

    David Goldfarb

  44. The exposome for kidney stones

    Article • Urolithiasis, November 2015, Springer Science + Business Media

    David Goldfarb

  45. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis

    Article • Urolithiasis, November 2015, Springer Science + Business Media

    David Goldfarb

  46. Urine proteomic analysis in cystinuric children with renal stones

    Article • Journal of Pediatric Urology, August 2015, Elsevier

    David Goldfarb

  47. The New Epidemiology of Nephrolithiasis

    Article • Advances in Chronic Kidney Disease, July 2015, Elsevier

    David Goldfarb

  48. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment

    Article • Nature Communications, June 2015, Springer Science + Business Media

    David Goldfarb

  49. Helicobacter pylori, Oxalobacter formigenes, and risk of kidney stones

    Article • Medical Hypotheses, June 2015, Elsevier

    David Goldfarb

  50. Cystine Growth Inhibition Through Molecular Mimicry: a New Paradigm for the Prevention of Crystal Diseases

    Article • Current Rheumatology Reports, April 2015, Springer Science + Business Media

    David Goldfarb

  51. MP34-16 PATIENTS WITH CYSTINURIA HAVE ALKALINE URINE DUE TO RENAL LOSS OF SULFATE PRECURSORS

    Article • The Journal of Urology, April 2015, Wolters Kluwer Health

    David Goldfarb

  52. Institutional Characteristics Associated with Receipt of Emergency Care for Obstructive Pyelonephritis at Community Hospitals

    Article • The Journal of Urology, March 2015, Wolters Kluwer Health

    David Goldfarb

  53. Enteric hyperoxaluria: an important cause of end-stage kidney disease

    Article • Nephrology Dialysis Transplantation, February 2015, Oxford University Press (OUP)

    David Goldfarb

  54. Pocket Guide to Kidney Stone Prevention

    Article • January 2015, Springer Science + Business Media

    David Goldfarb

  55. The Clinical Impact of Accurate Cystine Calculi Characterization Using Dual-Energy Computed Tomography

    Article • Case Reports in Radiology, January 2015, Hindawi Publishing Corporation

    David Goldfarb

  56. Dysphoria Induced in Dialysis Providers by Secondary Hyperparathyroidism

    Article • Clinical Journal of the American Society of Nephrology, December 2014, American Society of Nephrology

    Dr Geoffrey A Block, David Goldfarb

  57. Novel Cystine Ester Mimics for the Treatment of Cystinuria-induced Urolithiasis in a Knockout Mouse Model

    Article • Urology, November 2014, Elsevier

    David Goldfarb

  58. Risk of Chronic and End Stage Kidney Disease in Patients with Nephrolithiasis

    Article • The Journal of Urology, November 2014, Wolters Kluwer Health

    David Goldfarb

  59. The Search for Monogenic Causes of Kidney Stones

    Article • Journal of the American Society of Nephrology, October 2014, American Society of Nephrology

    David Goldfarb

  60. In Reply to ‘Role of Sodium Restriction in Recurrent Stone Formers With Hyperoxaluria’

    Article • American Journal of Kidney Diseases, September 2014, Elsevier

    David Goldfarb

  61. A Nomogram for the Prediction of Kidney Stone Recurrence

    Article • Journal of the American Society of Nephrology, August 2014, American Society of Nephrology

    David Goldfarb

  62. Twice-Weekly and Incremental Hemodialysis Treatment for Initiation of Kidney Replacement Therapy

    Article • American Journal of Kidney Diseases, August 2014, Elsevier

    Professor Kamyar Kalantar-Zadeh, David Goldfarb

  63. Medical Management of Kidney Stones: AUA Guideline

    Article • The Journal of Urology, August 2014, Wolters Kluwer Health

    David Goldfarb

  64. Guidelines for Reporting Case Studies on Extracorporeal Treatments in Poisonings: Methodology

    Article • Seminars in Dialysis, May 2014, Wiley

    David Goldfarb

  65. Facilitating the transition from physiology to hospital wards through an interdisciplinary case study of septic shock

    Article • BMC Medical Education, April 2014, Springer Science + Business Media

    David Goldfarb

  66. Urinary Stones

    Article • April 2014, Wiley

    David Goldfarb

  67. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria

    Article • Journal of Nephrology, April 2014, Springer Science + Business Media

    David Goldfarb

  68. MP25-14 KIDNEY STONES ARE A RISK FACTOR FOR CKD AND ESRD

    Article • The Journal of Urology, April 2014, Wolters Kluwer Health

    David Goldfarb

  69. Symptomatic Central Venous Stenosis in a Hemodialysis Patient Leading to Loss of Arteriovenous Access: A Case Report and Literature Review

    Article • Nephron Extra, March 2014, Karger Publishers

    David Goldfarb

  70. Urinary Lithogenic Risk Profile in Recurrent Stone Formers With Hyperoxaluria: A Randomized Controlled Trial Comparing DASH (Dietary Approaches to Stop Hypertension)-Style and Low-Oxalate Diets

    Article • American Journal of Kidney Diseases, March 2014, Elsevier

    Professor Kamyar Kalantar-Zadeh, David Goldfarb

  71. Zero Dark Thirty: A Nephrologist at the Movies

    Article • American Journal of Kidney Diseases, March 2014, Elsevier

    David Goldfarb

  72. How to Build a Kidney Stone Prevention Clinic

    Article • February 2014, Wiley

    David Goldfarb

  73. Acute Medical Aspects Related to Nephrolithiasis

    Article • January 2014, Endocrine Society

    David Goldfarb

  74. Hemodialysis clearance of glyphosate following a life-threatening ingestion of glyphosate-surfactant herbicide

    Article • Clinical Toxicology, January 2014, Taylor & Francis

    David Goldfarb

  75. Cystinuria: Assessing and Managing Risk

    Article • January 2014, Springer Science + Business Media

    David Goldfarb

  76. Bilateral Tubulocystic Renal Cell Carcinomas in Diabetic End-Stage Renal Disease: First Case Report with Cytogenetic and Ultrastructural Studies

    Article • Rare Tumors, December 2013, SAGE Publications

    David Goldfarb

  77. Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial)

    Article • The American Journal of Cardiology, December 2013, Elsevier

    David Goldfarb

  78. Kidney Stones and the Risk of Coronary Heart Disease

    Article • American Journal of Kidney Diseases, December 2013, Elsevier

    David Goldfarb

  79. Radioisotope blood volume measurement in hemodialysis patients

    Article • Hemodialysis International, November 2013, Wiley

    David Goldfarb

  80. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers

    Article • Urolithiasis, November 2013, Springer Science + Business Media

    David Goldfarb

  81. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD

    Article • American Journal of Kidney Diseases, November 2013, Elsevier

    David Goldfarb

  82. Dialysis Initiation: What's the Rush?

    Article • Seminars in Dialysis, September 2013, Wiley

    Professor Kamyar Kalantar-Zadeh, David Goldfarb

  83. Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

    Article • Clinical Journal of the American Society of Nephrology, August 2013, American Society of Nephrology

    David Goldfarb

  84. Review: Thiazide, citrate, or allopurinol reduces recurrence after ≥ 2 kidney stone episodes

    Article • Annals of Internal Medicine, July 2013, American College of Physicians

    David Goldfarb

  85. Monosodium Urate Stones Are Rare, and Urine pH Is Not Low in Cystinuria

    Article • American Journal of Kidney Diseases, July 2013, Elsevier

    David Goldfarb

  86. Update on cystinuria

    Article • Current Opinion in Nephrology & Hypertension, July 2013, Wolters Kluwer Health

    David Goldfarb

  87. Cocktail Party Nephrology

    Article • JAMA, June 2013, American Medical Association (AMA)

    David Goldfarb

  88. A Pilot Study of the Effect of Sodium Thiosulfate on Urinary Lithogenicity and Associated Metabolic Acid Load in Non-Stone Formers and Stone Formers with Hypercalciuria

    Article • PLoS ONE, April 2013, PLOS

    David Goldfarb

  89. 2107 PATHOPHYSIOLOGICAL BASES OF INTRA-RENAL CALCIFICATION IN MICE DEFICIENT FOR TAMM-HORSFALL PROTEIN (UROMODULIN)

    Article • The Journal of Urology, April 2013, Wolters Kluwer Health

    David Goldfarb

  90. Optimum Nutrition for Kidney Stone Disease

    Article • Advances in Chronic Kidney Disease, March 2013, Elsevier

    David Goldfarb

  91. Surgical Decompression is Associated with Decreased Mortality in Patients with Sepsis and Ureteral Calculi

    Article • The Journal of Urology, March 2013, Wolters Kluwer Health

    David Goldfarb

  92. Evidence for inheritance of medullary sponge kidney

    Article • Kidney International, February 2013, Elsevier

    David Goldfarb

  93. Metabolic Evaluation of First-time and Recurrent Stone Formers

    Article • Urologic Clinics of North America, February 2013, Elsevier

    David Goldfarb

  94. Pharmacologic Treatment of Kidney Stone Disease

    Article • Urologic Clinics of North America, February 2013, Elsevier

    David Goldfarb

  95. Hereditary causes of kidney stones and chronic kidney disease

    Article • Pediatric Nephrology, January 2013, Springer Science + Business Media

    David Goldfarb

  96. Minimal Change Disease and IgA Deposition: Separate Entities or Common Pathophysiology?

    Article • Case Reports in Nephrology, January 2013, Hindawi Publishing Corporation

    David Goldfarb

  97. Uric Acid Stones and Hyperuricosuria

    Article • Advances in Chronic Kidney Disease, November 2012, Elsevier

    David Goldfarb

  98. Capital Punishment: What Is the Appropriate Abbreviation for Partial Pressure of a Gas?

    Article • The American Journal of the Medical Sciences, September 2012, Elsevier

    David Goldfarb

  99. Laxative Abuse, Eating Disorders, and Kidney Stones: A Case Report and Review of the Literature

    Article • American Journal of Kidney Diseases, August 2012, Elsevier

    David Goldfarb

  100. Extracorporeal Treatment for Thallium Poisoning: Recommendations from the EXTRIP Workgroup

    Article • Clinical Journal of the American Society of Nephrology, July 2012, American Society of Nephrology

    Dr Thomas D Nolin, Darren Roberts, David Goldfarb

  101. The Older Adult Patient and Kidney Function

    Article • The Consultant Pharmacist, June 2012, American Society of Consultant Pharmacists

    David Goldfarb

  102. A Woman with Recurrent Calcium Phosphate Kidney Stones

    Article • Clinical Journal of the American Society of Nephrology, May 2012, American Society of Nephrology

    David Goldfarb

  103. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology

    Article • Clinical Toxicology, May 2012, Taylor & Francis

    David Goldfarb

  104. 1843 MANAGEMENT OF CYSTINURIC PATIENTS IN A DEDICATED STONE CLINIC DECREASES STONE EVENTS

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    David Goldfarb

  105. 2256 CLINICAL VALIDATION OF A NOVEL ASSAY USED FOR MONITORING TREATMENT OF PATIENTS WITH CYSTINURIA

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    David Goldfarb

  106. 2302 CYSTINE ANALOGS AS POTENTIAL THERAPEUTIC AGENTS FOR CYSTINURIA

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    David Goldfarb

  107. 842 ADMINISTRATION OF A UNIQUE RENOPROTECTIVE COCKTAIL IN A RAT MODEL: CAN WARM ISCHEMIA-REPERFUSION INJURY BE PREVENTED?

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    David Goldfarb

  108. Effect of Vitamin D Repletion on Urinary Calcium Excretion among Kidney Stone Formers

    Article • Clinical Journal of the American Society of Nephrology, March 2012, American Society of Nephrology

    David Goldfarb

  109. A New CJASN Feature: CJASN's eJournal Club (eJC)

    Article • Clinical Journal of the American Society of Nephrology, December 2011, American Society of Nephrology

    David Goldfarb

  110. Amelioration of Renal Ischemia-Reperfusion Injury With a Novel Protective Cocktail

    Article • The Journal of Urology, December 2011, Wolters Kluwer Health

    David Goldfarb

  111. New and emerging therapies for gout

    Article • Clinical Investigation, November 2011, OMICS Publishing Group

    David Goldfarb

  112. Oral Antibiotic Treatment of Helicobacter pylori Leads to Persistently Reduced Intestinal Colonization Rates with Oxalobacter formigenes

    Article • Journal of Endourology, November 2011, Mary Ann Liebert Inc

    David Goldfarb

  113. Genetic Causes of Kidney Stones and Kidney Failure

    Article • Clinical Reviews in Bone and Mineral Metabolism, September 2011, Springer Science + Business Media

    David Goldfarb

  114. Effect of diet orange soda on urinary lithogenicity

    Article • Urological Research, August 2011, Springer Science + Business Media

    David Goldfarb

  115. Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments

    Article • Clinical Trials, August 2011, SAGE Publications

    David Goldfarb

  116. Potential Pharmacologic Treatments for Cystinuria and for Calcium Stones Associated with Hyperuricosuria: Figure 1.

    Article • Clinical Journal of the American Society of Nephrology, July 2011, American Society of Nephrology

    David Goldfarb

  117. Ambient temperature as a contributor to kidney stone formation: implications of global warming

    Article • Kidney International, June 2011, Elsevier

    David Goldfarb

  118. Febuxostat in Gout: Serum Urate Response in Uric Acid Overproducers and Underexcretors

    Article • The Journal of Rheumatology, May 2011, The Journal of Rheumatology

    David Goldfarb

  119. Have Advances in Extracorporeal Removal Techniques Changed the Indications for Their Use in Poisonings?

    Article • Advances in Chronic Kidney Disease, May 2011, Elsevier

    David Goldfarb

  120. The Hemodialysis Machine: Where the Nephrologists and Toxicologists Meet

    Article • Advances in Chronic Kidney Disease, May 2011, Elsevier

    David Goldfarb

  121. Melamine-related kidney stones and renal toxicity

    Article • Nature Reviews Nephrology, March 2011, Springer Science + Business Media

    David Goldfarb

  122. Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

    Article • The American Journal of Medicine, February 2011, Elsevier

    David Goldfarb

  123. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation

    Article • Kidney International, December 2010, Elsevier

    David Goldfarb

  124. Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design

    Article • Science, October 2010, American Association for the Advancement of Science

    David Goldfarb

  125. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein

    Article • AJP Renal Physiology, September 2010, American Physiological Society

    David Goldfarb

  126. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

    Article • Advances in Therapy, August 2010, Springer Science + Business Media

    David Goldfarb

  127. The Normal Saline Ceremony

    Article • American Journal of Kidney Diseases, August 2010, Elsevier

    David Goldfarb

  128. Pathophysiology and treatment of cystinuria

    Article • Nature Reviews Nephrology, June 2010, Nature

    Professor Guillem Feixas, David Goldfarb

  129. Citrate, Malate and Alkali Content in Commonly Consumed Diet Sodas: Implications for Nephrolithiasis Treatment

    Article • The Journal of Urology, June 2010, Wolters Kluwer Health

    David Goldfarb

  130. Extracorporeal Removal Techniques for the Poisoned Patient: A Review for the Intensivist

    Article • Journal of Intensive Care Medicine, May 2010, SAGE Publications

    David Goldfarb

  131. 109: Febuxostat in Gout: Serum Urate Responses in Uric Acid Overproducers vs. Underexcretors

    Article • American Journal of Kidney Diseases, April 2010, Elsevier

    David Goldfarb

  132. Expanding the horizons of histoplasmosis: disseminated histoplasmosis in a renal transplant patient after a trip to Bangladesh

    Article • Transplant Infectious Disease, April 2010, Wiley

    David Goldfarb

  133. Update on the Pathophysiology and Management of Uric Acid Renal Stones

    Article • Current Rheumatology Reports, March 2010, Springer Science + Business Media

    David Goldfarb

  134. Response to “Chemistry misconceptions associated with understanding calcium and phosphate homeostasis”

    Article • AJP Advances in Physiology Education, March 2010, American Physiological Society

    David Goldfarb

  135. A Pilot Clinical Study to Evaluate Changes in Urine Osmolality and Urine cAMP in Response to Acute and Chronic Water Loading in Autosomal Dominant Polycystic Kidney Disease

    Article • Clinical Journal of the American Society of Nephrology, February 2010, American Society of Nephrology

    David Goldfarb

  136. Continuous Renal Replacement Therapy Does Not Have a Clear Role in the Treatment of Poisoning

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    David Goldfarb

  137. Metabolic Investigations: When and in Whom

    Article • January 2010, Springer Science + Business Media

    David Goldfarb

  138. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease

    Article • The American Journal of Cardiology, December 2009, Elsevier

    David Goldfarb

  139. Treatment of Pregabalin Toxicity by Hemodialysis in a Patient With Kidney Failure

    Article • American Journal of Kidney Diseases, December 2009, Elsevier

    David Goldfarb

  140. Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis

    Article • Kidney International, October 2009, Elsevier

    David Goldfarb

  141. Homocysteine Lowering and Cognition in CKD: The Veterans Affairs Homocysteine Study

    Article • American Journal of Kidney Diseases, September 2009, Elsevier

    David Goldfarb

  142. Nephrolithiasis

    Article • Annals of Internal Medicine, August 2009, American College of Physicians

    David Goldfarb

  143. The underutilization of hemodialysis in patients with salicylate poisoning

    Article • Kidney International, June 2009, Elsevier

    David Goldfarb

  144. Effect of the MTHFR C677T and A1298C Polymorphisms on Survival in Patients With Advanced CKD and ESRD: A Prospective Study

    Article • American Journal of Kidney Diseases, May 2009, Elsevier

    David Goldfarb

  145. Asymptomatic Nephrolithiasis Detected by Ultrasound

    Article • Clinical Journal of the American Society of Nephrology, March 2009, American Society of Nephrology

    David Goldfarb

  146. Future Directions in Nephrolithiasis Research

    Article • Advances in Chronic Kidney Disease, January 2009, Elsevier

    David Goldfarb

  147. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia

    Article • Kidney International, January 2009, Elsevier

    David Goldfarb

  148. Prospects for Dietary Therapy of Recurrent Nephrolithiasis

    Article • Advances in Chronic Kidney Disease, January 2009, Elsevier

    David Goldfarb

  149. Effect of two sports drinks on urinary lithogenicity

    Article • Urological Research, December 2008, Springer Science + Business Media

    David Goldfarb

  150. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation

    Article • Kidney International, December 2008, Elsevier

    David Goldfarb

  151. Use of hemodialysis and hemoperfusion in poisoned patients

    Article • Kidney International, November 2008, Elsevier

    David Goldfarb

  152. The Luminal N-Terminus of Yeast Nvj1 is an Inner Nuclear Membrane Anchor

    Article • Traffic, October 2008, Wiley

    David Goldfarb

  153. Cystinuria

    Article • Seminars in Nephrology, March 2008, Elsevier

    David Goldfarb

  154. The Association of Nephrolithiasis With Hypertension and Obesity: A Review

    Article • American Journal of Hypertension, March 2008, Oxford University Press (OUP)

    David Goldfarb

  155. Homocysteine Lowering and Severe Kidney Disease—Reply

    Article • JAMA, January 2008, American Medical Association (AMA)

    David Goldfarb

  156. Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease

    Article • JAMA, September 2007, American Medical Association (AMA)

    David Goldfarb

  157. Diagnosis of Medullary Sponge Kidney by Computed Tomographic Urography

    Article • American Journal of Kidney Diseases, July 2007, Elsevier

    David Goldfarb

  158. A Randomized, Controlled Trial of Lactic Acid Bacteria for Idiopathic Hyperoxaluria

    Article • Clinical Journal of the American Society of Nephrology, May 2007, American Society of Nephrology

    David Goldfarb

  159. Adverse Metabolic Side Effects of Thiazides: Implications for Patients With Calcium Nephrolithiasis

    Article • The Journal of Urology, April 2007, Wolters Kluwer Health

    David Goldfarb

  160. Hyperkalemia: Newer Considerations

    Article • The AMA Journal of Ethic, April 2007, American Medical Association (AMA)

    David Goldfarb

  161. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness

    Article • Journal of Applied Physiology, April 2007, American Physiological Society

    David Goldfarb

  162. Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia

    Article • Dialysis & Transplantation, November 2006, Wiley

    David Goldfarb

  163. Predictive Value of a Positive Fecal Occult Blood Test Increases as the Severity of CKD Worsens

    Article • American Journal of Kidney Diseases, October 2006, Elsevier

    David Goldfarb

  164. The Role of Continuous Renal Replacement Therapy in the Treatment of Poisoning

    Article • Seminars in Dialysis, September 2006, Wiley

    David Goldfarb

  165. The Availability and Use of Charcoal Hemoperfusion in the Treatment of Poisoned Patients

    Article • American Journal of Kidney Diseases, August 2006, Elsevier

    David Goldfarb

  166. Strategies for preventing calcium oxalate stones

    Article • Canadian Medical Association Journal, May 2006, Canadian Medical Association (CMA)

    David Goldfarb

  167. Positive Predictive Value of Fecal Occult Blood Testing in Asymptomatic Average-Risk Patients with Varying Degrees of Chronic Kidney Disease

    Article • Gastrointestinal Endoscopy, April 2006, Elsevier

    David Goldfarb

  168. Urinary cystine excretion and capacity in patients with cystinuria

    Article • Kidney International, March 2006, Elsevier

    David Goldfarb

  169. Chitosan does not reduce post-prandial urinary oxalate excretion

    Article • Urological Research, February 2006, Springer Science + Business Media

    David Goldfarb

  170. Use of a probioitic to decrease enteric hyperoxaluria

    Article • Kidney International, September 2005, Elsevier

    David Goldfarb

  171. Nephrolithiasis complicating treatment of diabetes insipidus

    Article • Urological Research, May 2005, Springer Science + Business Media

    David Goldfarb

  172. Effect of Cystine-Binding Thiol Drugs on Urinary Cystine Capacity in Patients with Cystinuria

    Article • Journal of Endourology, April 2005, Mary Ann Liebert Inc

    David Goldfarb

  173. A twin study of genetic and dietary influences on nephrolithiasis: A report from the Vietnam Era Twin (VET) Registry

    Article • Kidney International, March 2005, Elsevier

    David Goldfarb

  174. RE: ACUTE CAFFEINE EFFECTS ON URINE COMPOSITION AND CALCIUM KIDNEY STONE RISK IN CALCIUM STONE FORMERS

    Article • The Journal of Urology, March 2005, Wolters Kluwer Health

    David Goldfarb

  175. Hyperkalemia after the Publication of RALES

    Article • New England Journal of Medicine, December 2004, New England Journal of Medicine (NEJM/MMS)

    David Goldfarb

  176. Uric acid stones following hepatic transplantation

    Article • Urological Research, November 2004, Springer Science + Business Media

    David Goldfarb

  177. Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study

    Article • Clinical Trials, October 2004, SAGE Publications

    David Goldfarb

  178. AA-type amyloidosis associated with non-Hodgkin’s lymphoma: A case report

    Article • Human Pathology, August 2004, Elsevier

    David Goldfarb

  179. Occupational risk for nephrolithiasis and bladder dysfunction in a chauffeur

    Article • Urological Research, February 2004, Springer Science + Business Media

    David Goldfarb

  180. Microorganisms and Calcium Oxalate Stone Disease

    Article • Nephron Physiology, January 2004, Karger Publishers

    David Goldfarb

  181. The association of nephrolithiasis with cystic fibrosis

    Article • American Journal of Kidney Diseases, July 2003, Elsevier

    David Goldfarb

  182. Increasing prevalence of kidney stones in the United States

    Article • Kidney International, May 2003, Elsevier

    David Goldfarb

  183. Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam

    Article • American Journal of Kidney Diseases, January 2003, Elsevier

    Michael B Stokes, David Goldfarb

  184. The Absence of Rhabdomyolysis-induced Renal Failure Following the World Trade Center Collapse

    Article • The American Journal of Medicine, August 2002, Elsevier

    David Goldfarb

  185. Diagnostic value of iron indices in hemodialysis patients receiving epoetin

    Article • Kidney International, July 2001, Elsevier

    David Goldfarb

  186. EFFECT OF GRAPEFRUIT JUICE ON URINARY LITHOGENICITY

    Article • The Journal of Urology, July 2001, Wolters Kluwer Health

    David Goldfarb

  187. EFFECT OF GRAPEFRUIT JUICE ON URINARY LITHOGENICITY

    Article • The Journal of Urology, July 2001, Wolters Kluwer Health

    David Goldfarb

  188. Cystinuria

    Article • April 2001, Wiley

    David Goldfarb

  189. CLINICAL USE OF CYSTINE SUPERSATURATION MEASUREMENTS

    Article • The Journal of Urology, November 2000, Wolters Kluwer Health

    David Goldfarb

  190. CLINICAL USE OF CYSTINE SUPERSATURATION MEASUREMENTS

    Article • The Journal of Urology, November 2000, Wolters Kluwer Health

    David Goldfarb

  191. Indications for Hospitalization of Patients With Hyperkalemia

    Article • Archives of Internal Medicine, June 2000, American Medical Association (AMA)

    David Goldfarb

  192. Fomepizole for ethyleneglycol poisoning

    Article • The Lancet, November 1999, Elsevier

    David Goldfarb

  193. Beverages, diet, and prevention of kidney stones

    Article • American Journal of Kidney Diseases, February 1999, Elsevier

    David Goldfarb

  194. Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

    Article • New England Journal of Medicine, August 1998, New England Journal of Medicine (NEJM/MMS)

    David Goldfarb

  195. Calcified Mass in a Patient on Long-Term Hemodialysis

    Article • New England Journal of Medicine, May 1998, New England Journal of Medicine (NEJM/MMS)

    David Goldfarb

  196. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus

    Article • American Journal of Kidney Diseases, April 1997, Elsevier

    Michael B Stokes, David Goldfarb

  197. Effects of acid-base variables on ion transport in rat colon.

    Article • Journal of Clinical Investigation, June 1988, American Society for Clinical Investigation

    David Goldfarb

  198. Metabolic Evaluation and Prevention of Renal Stone Disease

    Article • Wiley

    David Goldfarb